Searched for
MILD COVID VARIANT
‘Cicada’ COVID variant BA 3.2 spreads to 25 states — what symptoms you should not ignoreThe BA.3.2 COVID-19 subvariant, known as “Cicada,” is spreading across the United States, with cases reported in 25 states and over 20 coun...- BA.3.2 Cicada COVID Variant symptoms: How is it different from previous COVID strains, should you be worried?New Covid variant 2026 Cicada symptoms: The highly mutated new BA.3.2 Cicada COVID Variant has now spread to at least 23 countries, sparkin...
- Should you be worried about Covid variant JN.1? Check what doctors are sayingDelhi doctors reassure public about the JN.1 variant. They report mild symptoms among patients. Hospitals are preparing with necessary equi...
- Covid cases rising in Singapore, India: What's JN.1 variant driving the surge, its symptoms, severity, precautions and vaccine responseCovid news: Several Asian countries, including Singapore and Hong Kong, are experiencing a rise in COVID-19 cases driven by the JN.1 varian...
- Current Covid cases are mild infections, nothing to worry: Delhi health ministerIndia has recorded 573 fresh cases of COVID-19 and the number of active cases has increased to 4,565. Two new fatalities due to the disease...
- COVID-19 JN.1 targets another state; Manipur records first case of new variantManipur reported its first case of COVID-19 new sub-variant. The infected individual, who hails from Paomata in Senapati district, had trav...
- 22 cases of Covid's JN.1 variant detected in country till ThursdayThose infected had mild upper respiratory tract infection with symptoms of mild dry cough, sore throat with or without fever, they said. In...
- Four cases of COVID sub-variant JN.1 in Rajasthan, health dept issues advisoryCovid cases of the new sub-variant have been reported in Kerala, Karnataka, Maharashtra, Delhi and Goa. In its advisory on Thursday, the st...
- 21 cases of Covid sub-variant JN.1 found in three states, says NITI Aayog member V K PaulAs many as 21 cases of COVID-19 sub-variant JN.1 have been detected across the country till now, NITI Aayog member (Health) Dr V K Paul sai...
- Is the new COVID JN.1 variant more dangerous than previous ones? Here is what doctors are sayingA new strain of Covid-19, named JN.1, has been detected in Karakulam, Thiruvananthapuram district of Kerala. This variant, a descendant of ...
- Covid JN.1 virus arrives in India: What are the symptoms, precautions and should you worry?A new sub-variant of the coronavirus, named JN.1, has been detected in a woman from Kerala, marking the first case in India. JN.1 is closel...
- India sees over 5,300 fresh Covid cases in 24 hours, highest rise in 7 monthsSix deaths were reported in past 24 hours, taking up the overall toll to 530929. A total of 1.6 lakh tests were conducted over the past 24 ...
- Covid variant XBB.1.16 s driving up cases in India. Symptoms, precautions and other key thingsThe common symptoms of this XBB 1.16 variant include the signs of upper respiratory illnesses like headache, sore throat, and blocked nose ...
- View: Hybrid immunity may be there but basic precautions will keep us safe from next COVID waveThe risk of a surge in cases, especially in hospitalisations, is still considered low in India mainly because of hybrid immunity. It refers...
- 12 cases of Omicron subvariants detected in Tamil NaduThe Minister informed that 300 samples were sent to the Centre for DNA Fingerprinting and Diagnostics, Hyderabad of which 12 tested positiv...
- Omicron sub-variants cause only mild disease: Covid working group headMaharashtra on Saturday reported its first cases of the Covid-19 infection with BA.4 and BA.5 sub-variants of the Omicron strain of the vir...
- Omicron has higher risk of reinfection than Delta and Beta variants: Singapore's health ministry"There is a higher likelihood of individuals who have recovered from COVID-19 to be reinfected with the Omicron variant," Channel News Asia...
- GSK says antibody drug 'Sotrovimab' works against OmicronUK's Medicines and Healthcare products Regulatory Agency has approved sotrovimab, a Covid-19 treatment which has been developed by GSK and ...
- Suspected Omicron cases mild: Leading South Africa doctorAngelique Coetzee, chair of the South African Medical Association, told AFP she had seen around 30 patients over the past 10 days who teste...
- Study finds 96 per cent of COVID-19 patients have antibodies year after recoveryThe study looked at results from 250 people aged 21-78 who tested positive for the virus between February and April last year and found tha...
Load More
